Issuu on Google+

Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2014 Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Respiratory Tract Inflammatory Disorders Market in subject line and your contact details. Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2014, provides an overview of the Respiratory Tract Inflammatory Disorders’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Respiratory Tract Inflammatory Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Respiratory Tract Inflammatory Disorders and special features on late-stage and discontinued projects. Complete report is spread across 42 pages and available @ http://www.reportsnreports.com/reports/280827-respiratory-tractinflammatory-disorders-pipeline-review-h1-2014.html . The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx? name=280827. Scope The report provides a snapshot of the global therapeutic landscape of Respiratory Tract Inflammatory Disorders - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2014


- The report reviews key players involved in the therapeutics development for Respiratory Tract Inflammatory Disorders and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Respiratory Tract Inflammatory Disorders products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Respiratory Tract Inflammatory Disorders pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Respiratory Tract Inflammatory Disorders - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Respiratory Tract Inflammatory Disorders pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx? name=280827. List of Tables Number of Products under Development for Respiratory Tract Inflammatory Disorders, H1 2014 7 Number of Products under Development for Respiratory Tract Inflammatory Disorders Comparative Analysis, H1 2014 8 Number of Products under Development by Companies, H1 2014 9 Number of Products under Investigation by Universities/Institutes, H1 2014 10 Comparative Analysis by Late Stage Development, H1 2014 11 Comparative Analysis by Early Stage Development, H1 2014 12 Products under Development by Companies, H1 2014 13

Products under Investigation by Universities/Institutes, H1 2014 14 Respiratory Tract Inflammatory Disorders - Pipeline by Merck & Co., Inc., H1 2014 15 Respiratory Tract Inflammatory Disorders - Pipeline by UCB S.A., H1 2014 16 Respiratory Tract Inflammatory Disorders - Pipeline by Verona Pharma Plc, H1 2014 17 Respiratory Tract Inflammatory Disorders - Pipeline by GlycoMar Limited, H1 2014 18

Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2014


Respiratory Tract Inflammatory Disorders - Pipeline by Trino Therapeutics Ltd, H1 2014 19 Respiratory Tract Inflammatory Disorders - Pipeline by Covigilance sro, H1 2014 20 Assessment by Monotherapy Products, H1 2014 21 Number of Products by Stage and Target, H1 2014 23 Number of Products by Stage and Mechanism of Action, H1 2014 25 Number of Products by Stage and Route of Administration, H1 2014 27 Number of Products by Stage and Molecule Type, H1 2014 29 Respiratory Tract Inflammatory Disorders - Dormant Projects, H1 2014 39 List of Figures Number of Products under Development for Respiratory Tract Inflammatory Disorders, H1 2014 7 Number of Products under Development for Respiratory Tract Inflammatory Disorders Comparative Analysis, H1 2014 8 Number of Products under Development by Companies, H1 2014 9 Comparative Analysis by Early Stage Products, H1 2014 12 Assessment by Monotherapy Products, H1 2014 21 Number of Products by Top 10 Target, H1 2014 22 Number of Products by Stage and Top 10 Target, H1 2014 23 Number of Products by Top 10 Mechanism of Action, H1 2014 24 Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 25 Number of Products by Top 10 Route of Administration, H1 2014 26 Number of Products by Stage and Top 10 Route of Administration, H1 2014 27 Number of Products by Top 10 Molecule Type, H1 2014 28 Number of Products by Stage and Top 10 Molecule Type, H1 2014 29 Inquiry Before Buying @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=280827 Explore Report on Pharmaceuticals & Therapeutic Market. Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2014� report OR for any other market research and intelligence needs you may have for your business.

Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2014


Respiratory Tract Inflammatory Disorders Market